Impact of high‐altitude therapy on type‐2 immune responses in asthma patients-Reference-Cited by-同舟云学术

Impact of high‐altitude therapy on type‐2 immune responses in asthma patients

Published:2019-11-03 Issue:1 Volume:75 Page:84-94
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Boonpiyathad Tadech¹²³^ORCID,Capova Gertruda³⁴,Duchna Hans‐Werner³⁴,Croxford Andrew L.⁵,Farine Herve⁵,Dreher Anita¹⁴,Clozel Martine⁵,Schreiber Juliane⁴,Kubena Petr⁴,Lunjani Nonhlanhla¹³,Mirer David¹,Rückert Beate¹,Satitsuksanoa Pattraporn¹³,Tan Ge¹^ORCID,Groenen Peter M. A.⁵,Bersuch Eugen³⁴,Akdis Mübeccel¹^ORCID,Strasser Daniel S.⁵,Renner Ellen D.³⁴⁶,Akdis Cezmi A.¹³

Affiliation:

1. Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland

2. Department of Medicine Phramongkutklao Hospital Bangkok Thailand

3. Christine Kühne Center for Allergy Research and Education Davos Switzerland

4. Hochgebirgsklinik Davos Davos Switzerland

5. Drug Discovery Idorsia Pharmaceuticals Ltd. Allschwil Switzerland

6. Chair and Institute of Environmental Medicine – UNIKA‐T TU Munich and Helmholtz Zentrum Munich Munich Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link